GSK plc
GSK
$51.87
-$1.09-2.06%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.43B | 7.78B | 7.53B | 7.22B | 4.43B |
| Total Depreciation and Amortization | 1.07B | 1.60B | 2.03B | 3.12B | 3.36B |
| Total Amortization of Deferred Charges | 292.59M | 292.59M | 292.59M | 270.22M | 270.22M |
| Total Other Non-Cash Items | 4.11B | 3.58B | 2.91B | 3.26B | 2.79B |
| Change in Net Operating Assets | -808.80M | -2.93B | -2.49B | -3.64B | -817.76M |
| Cash from Operations | 11.10B | 10.33B | 10.27B | 10.22B | 10.03B |
| Capital Expenditure | -1.91B | -1.82B | -1.79B | -1.72B | -1.70B |
| Sale of Property, Plant, and Equipment | 63.70M | 66.41M | 31.97M | 92.80M | 87.36M |
| Cash Acquisitions | -3.98B | -3.08B | -2.23B | -2.26B | -1.10B |
| Divestitures | 346.48M | 289.22M | -35.98M | -43.72M | -48.97M |
| Other Investing Activities | -807.82M | -1.54B | -1.56B | -1.84B | -1.90B |
| Cash from Investing | -6.29B | -6.08B | -5.58B | -5.77B | -4.66B |
| Total Debt Issued | 1.95B | 2.32B | 3.19B | 3.98B | 4.06B |
| Total Debt Repaid | -1.17B | -1.79B | -1.93B | -3.00B | -3.55B |
| Issuance of Common Stock | 10.00M | 11.00M | 15.00M | 14.00M | 15.00M |
| Repurchase of Common Stock | -1.20B | -1.46B | -1.38B | -1.13B | -808.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.55B | -3.46B | -3.38B | -3.31B | -3.23B |
| Other Financing Activities | -964.00M | -764.00M | -1.02B | -1.01B | -829.00M |
| Cash from Financing | -5.40B | -5.72B | -5.00B | -4.94B | -4.78B |
| Foreign Exchange rate Adjustments | 18.41M | -7.06M | -23.56M | 39.93M | -83.87M |
| Miscellaneous Cash Flow Adjustments | 56.92M | -- | -- | -- | -- |
| Net Change in Cash | -514.09M | -1.47B | -336.31M | -451.89M | 503.86M |